Dimensional Fund Advisors LP Durect Corp Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.43 - $5.9 $11,791 - $161,789	-27,422 Reduced 10.42%	235,818 $136,000
Q1 2022 May 13, 2022	SELL	$0.55 - $0.98 $7,563 - $13,476	-13,752 Reduced 4.96%	263,240 $176,000
Q4 2021 Feb 09, 2022	SELL	$0.9 - $1.31 $44,121 - $64,221	-49,024 Reduced 15.04%	276,992 $273,000
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $338,923 - $450,964	-280,102 Reduced 46.21%	326,016 $417,000
Q2 2021 Aug 12, 2021	SELL	$1.6 - $2.02 $48,366 - $61,062	-30,229 Reduced 4.75%	606,118 $988,000
Q1 2021 May 14, 2021	BUY	$1.86 - $2.87 $1.18 Million - $1.83 Million	636,347 New	636,347 $1.26 Million

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.